Preventing Hepatitis B Reactivation Due to Immunosuppressive Drug Treatments

被引：53
|
作者：
Perrillo, Robert P. [1 ]
Martin, Paul [2 ]
Lok, Anna S. [3 ]
机构：
[1] Baylor Univ, Med Ctr, Hepatol Div, Dallas, TX USA
[2] Univ Miami, Div Hepatol, Miami, FL USA
[3] Univ Michigan, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2015年 / 313卷 / 16期
关键词：
VIRUS REACTIVATION; INFECTION PRIOR; RECOMMENDATIONS; CHEMOTHERAPY; LAMIVUDINE; LYMPHOMA; AGENTS;
D O I：
10.1001/jama.2015.2571
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1617 / 1618
页数：2
相关论文
共 50 条
  • [41] Hepatitis B reactivation following immunosuppressive therapy and screening adherence: a neglected problem?
    Borde, J. P.
    Kern, W. V.
    Becker, J.
    Bertz, H.
    Huebner, J.
    Offensperger, W. B.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (28-29) : 1458 - 1462
  • [42] Strategies to Prevent Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Therapy
    Hsu, Chiun
    Wei, Shu-Chen
    Cheng, Ann-Lii
    Chen, Pei-Jer
    HEPATOLOGY, 2009, 50 (02) : 654 - 655
  • [43] Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification
    Wai-Kay Seto
    World Journal of Hepatology, 2015, (06) : 825 - 830
  • [44] Hepatitis B virus reactivation following immunosuppressive therapy: Guidelines for prevention and management
    Lubel, J. S.
    Testro, A. G.
    Angus, P. W.
    INTERNAL MEDICINE JOURNAL, 2007, 37 (10) : 705 - 712
  • [45] Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive Treatment
    Tsai, Yu-Fen
    Hsu, Chin-Mu
    Hsiao, Hui-Hua
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (04):
  • [46] Reactivation of Hepatitis B During Immunosuppressive Therapy: Potentially Fatal Yet Preventable
    Lok, Anna S. F.
    Ward, John W.
    Perrillo, Robert P.
    McMahon, Brian J.
    Liang, T. Jake
    ANNALS OF INTERNAL MEDICINE, 2012, 156 (10) : 743 - 745
  • [47] Cyclophosphamide/docetaxel/epirubicinFulminant hepatitis due to hepatitis B reactivation: case report
    Reactions Weekly, 2013, 1452 (1) : 14 - 14
  • [48] Hepatitis B: new treatments and drug resistance
    Locarnini, S. A.
    ANTIVIRAL THERAPY, 2010, 15 : A4 - A4
  • [49] MORTALITY DUE TO REACTIVATION HEPATITIS B IN AN HIV POSITIVE PATIENT
    Niess, Meredith
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 : S360 - S361
  • [50] Fulminant hepatic failure due to hepatitis B reactivation in pregnancy
    Evers, A. R.
    Butwick, A. J.
    ANESTHESIOLOGY, 2007, 106 (05) : B105 - B105
12345